Advanced diagnostic technologies for early-stage detection of cancer are essential for
proper management and guided therapeutics to increase chances of survival for patients …

Targeting cell surface receptors for specific drug delivery in cancer has garnered lot of
attention. Urokinase plasminogen activator receptor (uPAR), a surface biomarker, is …

B-cell epitope mapping is an approach that can identify and characterise specific antigen
binding sites of B-cell receptors and secreted antibodies. The ability to determine the …

Fluorine doped tin oxide (FTO) electrochemical immunosensor has been developed for
rapid detection of urokinase type plasminogen activator receptor (uPAR)-a biomarker for …

Compared with other nanomaterials, surface-modified iron oxide nanoparticles (IONPs)
have gained attraction for cancer therapy applications due to its low toxicity, and long …

The urokinase receptor (uPAR) is a glycosylphosphatidylinositol (GPI)-anchored protein that
promotes tissue remodeling, tumor cell adhesion, migration and invasion. uPAR mediates …

Receptor dimerization of urokinase-type plasminogen activator receptor (uPAR) was
previously identified at protein level and on cell surface. Recently, a dimeric form of mouse …

Targeting peptides are a promising tool for early diagnosis and therapy of cancer.
Overexpression of urokinase plasminogen activator receptor (uPAR) leads to the …

Hemostasis is a delicate balance between coagulation and fibrinolysis that regulates the
formation and removal of fibrin, respectively. Positive and negative feedback loops and …

Increased use of pesticides globally has led to harmful consequences on the environment,
livestock, animals, as well as humans. Hence, its detection in animal feed, vegetables …